Fig. 4

Biotransformation pathway for the conversion of ginsenosides Rb1, Rb2, and Rc to APPD via Rd, F2, C-K, C-Y, and C-Mc by DT-bgl supplemented with CB-bgl. The dotted line indicates a weak activity
Biotransformation pathway for the conversion of ginsenosides Rb1, Rb2, and Rc to APPD via Rd, F2, C-K, C-Y, and C-Mc by DT-bgl supplemented with CB-bgl. The dotted line indicates a weak activity